<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We analyzed structural motifs of <z:chebi fb="7" ids="16670">peptides</z:chebi> bound to HLA-DR4 (DRB1*0405 and DRB1*0406) and DR9 (DRB1*0901) and found that: (a) AxxBxC motif where A, B, and C are hydrophobic, hydrophobic, and neutral, respectively, is important for binding to DR4; (b) Gln (Q) or Ser at position C allow high-affinity binding specific to DRB1*0406 which is strongly associated with <z:e sem="disease" ids="C0854359" disease_type="Disease or Syndrome" abbrv="">insulin autoimmune syndrome</z:e>; (c) among human insulin-derived <z:chebi fb="7" ids="16670">peptide</z:chebi> fragments, the TSICSLYQLE of the human insulin alpha chain, which is exposed only under reducing conditions, has the highest affinity specific to DRB1*0406 by binding with the IxxLxQ motif; (d) a short-term human insulin-specific T cell line recognizes a <z:chebi fb="7" ids="16670">peptide</z:chebi> fragment containing the IxxLxQ motif as a major T cell <z:chebi fb="0" ids="53000">epitope</z:chebi>; and (e) in the AxxB motif, where A and B need to be hydrophobic for binding to DR9, neutral Ser is exceptionally allowed at position B </plain></SENT>
<SENT sid="1" pm="."><plain>The implications of our results are discussed in light of the HLA-DR4-associated susceptibility to <z:e sem="disease" ids="C0854359" disease_type="Disease or Syndrome" abbrv="">insulin autoimmune syndrome</z:e> and HLA-DR9-associated susceptibility to <z:hpo ids='HP_0003621'>juvenile-onset</z:hpo> <z:hpo ids='HP_0003473'>myasthenia</z:hpo> gravis and <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, in particular T cell responses to autoantigens </plain></SENT>
</text></document>